Financial News Feed

Previous Hold Today ALDX ranks #3754 as HOLD CANDIDATE. Next Hold
Today ALDX ranks #3754 as HOLD CANDIDATE.

ALDX stock Aldeyra Therapeutics

ALDX stock
Aldeyra Therapeutics

Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. The Earnings Yield for Armstrong Floori...

Read more

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the ...

Read more

Investors sentiment decreased to 2.68 in 2018 Q3. Its down 1.76, from 4.44 in 2018Q2. It is negative, as 8 investors sold Aldeyra Therapeutics, Inc. shares while 11 reduced holdings. 26 funds opened p...

Read more

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has made the gainer list looking back over the past full-year. During that time period, shares have seen a bump of28.84%. Many investors will be watching to se...

Read more

Investors sentiment decreased to 2.68 in Q3 2018. Its down 1.76, from 4.44 in 2018Q2. It turned negative, as 8 investors sold Aldeyra Therapeutics, Inc. shares while 11 reduced holdings. 26 funds open...

Read more

Sentiment for Aldeyra Therapeutics (NASDAQ:ALDX) Aldeyra Therapeutics (NASDAQ:ALDX) institutional sentiment decreased to 2.68 in Q3 2018. Its down -1.76, from 4.44 in 2018Q2. The ratio dropped, as 51 ...

Read more

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to inventing, developing and commercializing next-generation medicines to improve the lives of patients with immune...

Read more

Investors sentiment decreased to 2.68 in 2018 Q3. Its down 1.76, from 4.44 in 2018Q2. It fall, as 8 investors sold Aldeyra Therapeutics, Inc. shares while 11...

Read more

Aldeyra Therapeutics (NASDAQ:ALDX) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Several other research a...

Read more

BidaskClub upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX) from a sell rating to a hold rating in a report released on Thursday morning. A number of other equities analysts have also recently we...

Read more

Aldeyra Therapeutics, Inc. (NasdaqCM:ALDX) has a current EV or Enterprise Value of 238319. The EV displays how the market assigns value to a firm as a whole. EV is generally a modification of market c...

Read more

Legacy Reserves Inc. (NasdaqGS:LGCY) currently has a current ratio of 0.15. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of cu...

Read more

Aldeyra Therapeutics, Inc. (NasdaqCM:ALDX) has a Value Composite score of 90. Developed by James O’Shaughnessy, the VC score uses six valuation ratios. These ratios are price to earnings, price to c...

Read more

Sienna Senior Living Inc. (TSX:SIA) boasts a Price to Book ratio of 1.814405. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book ...

Read more

Investors sentiment decreased to 2.68 in 2018 Q3. Its down 1.76, from 4.44 in 2018Q2. It fall, as 8 investors sold Aldeyra Therapeutics, Inc. shares while 11...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank